Zobrazeno 1 - 10
of 371
pro vyhledávání: '"Michael Staehler"'
Autor:
Robert J. Motzer, Jean-François Martini, Xinmeng J. Mu, Michael Staehler, Daniel J. George, Olga Valota, Xun Lin, Hardev S. Pandha, Keith A. Ching, Alain Ravaud
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
Based on the S-TRAC results, sunitinib is approved as adjuvant treatment for adult patients at high risk of recurrent RCC following nephrectomy. Here, the authors report the results of an integrated multi-omics tumor analysis of 171 patients from the
Externí odkaz:
https://doaj.org/article/a7d75a60a97442e0a1d0bfad87ff00d3
Autor:
Stefanie Zschäbitz, Marie Mikuteit, Christine Stöhr, Edwin Herrmann, Iris Polifka, Abbas Agaimy, Lutz Trojan, Philipp Ströbel, Frank Becker, Christian Wülfing, Peter Barth, Michael Stöckle, Michael Staehler, Christian Stief, Axel Haferkamp, Markus Hohenfellner, Stefan Duensing, Stephan Macher-Göppinger, Bernd Wullich, Joachim Noldus, Walburgis Brenner, Frederik C. Roos, Bernhard Walter, Wolfgang Otto, Maximilian Burger, Andres Jan Schrader, Arndt Hartmann, Franziska Erlmeier, Sandra Steffens
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-12 (2022)
Abstract Background Nectin-4 contributes to tumor proliferation, lymphangiogenesis and angiogenesis in malignant tumors and is an emerging target in tumor therapy. In renal cell carcinoma (RCC) VEGF-directed tyrosine kinase inhibitors and checkpoint
Externí odkaz:
https://doaj.org/article/f48c4647fe714704ac7639eb9dc60db9
Autor:
Vinh Ngoc Bui, Lena M. Unterrainer, Matthias Brendel, Sophie C. Kunte, Adrien Holzgreve, Fabian Allmendinger, Peter Bartenstein, Frederick Klauschen, Marcus Unterrainer, Michael Staehler, Stephan Ledderose
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 3095 (2023)
In renal cell carcinoma (RCC), accurate imaging methods are required for treatment planning and response assessment to therapy. In addition, there is an urgent need for new therapeutic options, especially in metastatic RCC. One way to combine diagnos
Externí odkaz:
https://doaj.org/article/84e096e7d1ae45318b188c585e1092ea
Autor:
Lorenz Birnbacher, Margarita Braunagel, Marian Willner, Mathias Marschner, Fabio De Marco, Manuel Viermetz, Sigrid Auweter, Susan Notohamiprodjo, Katharina Hellbach, Mike Notohamiprodjo, Michael Staehler, Daniela Pfeiffer, Maximilian F Reiser, Franz Pfeiffer, Julia Herzen
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0279323 (2023)
BackgroundThe differentiation of minimal-fat-or low-fat-angiomyolipomas from other renal lesions is clinically challenging in conventional computed tomography. In this work, we have assessed the potential of grating-based x-ray phase-contrast compute
Externí odkaz:
https://doaj.org/article/25939d4472a84d9fa18067077369515c
Autor:
Jan-Niclas Mumm, Dr., Theresa Vilsmaier, Dr., Julius M. Schuetz, Dr., Severin Rodler, Dr., Alaleh Zati Zehni, Dr., Ricarda M. Bauer, Prof., Michael Staehler, Prof., Christian G. Stief, Prof., Falk Batz, Dr.
Publikováno v:
Sexual Medicine, Vol 9, Iss 4, Pp 100380- (2021)
ABSTRACT: Introduction: The COVID-19 pandemic drastically altered the way of life around the world. Due to social distancing measures, contact restrictions and fears of infection, social life has changed significantly. These measures along with the s
Externí odkaz:
https://doaj.org/article/a321f9308a274201894ae1b1dc82766e
Autor:
Giuseppe Magistro, Patrick Bregenhorn, Bernhard Krauß, Dominik Nörenberg, Melvin D’Anastasi, Anno Graser, Philipp Weinhold, Frank Strittmatter, Christian G. Stief, Michael Staehler
Publikováno v:
BMC Urology, Vol 19, Iss 1, Pp 1-5 (2019)
Abstract Background We analysed in vitro the appearance of commonly used ureteral stents with dual-energy computed tomography (DECT) and we used these characteristics to optimize the differentiation between stents and adjacent stone. Methods We analy
Externí odkaz:
https://doaj.org/article/18abc1552537418397da613c451d4bae
Autor:
Lena M. Mittlmeier, Stephan T. Ledderose, Melanie Schott, Matthias Brendel, Leonie Beyer, Sebastian Theurich, Doris Mayr, Christoph Walz, Wolfgang G. Kunz, Jens Ricke, Peter Bartenstein, Harun Ilhan, Michael Staehler, Marcus Unterrainer
Publikováno v:
Diagnostics, Vol 11, Iss 3, p 423 (2021)
We present a 71-year-old female patient who underwent 18F-PSMA-1007 PET/CT for suspected metastatic renal cell carcinoma (RCC), as RCC also shows high PSMA-expression in tumor neovascularization. 18F-PSMA-1007 PET/CT showed a high PSMA-avidity in the
Externí odkaz:
https://doaj.org/article/34396a99dc55496c97087f1e80ebb792
Autor:
Moritz L. Schnitzer, Laura Sabel, Vincent Schwarze, Constantin Marschner, Matthias F. Froelich, Philipp Nuhn, Yannick Falck, Maria-Magdalena Nuhn, Saif Afat, Michael Staehler, Johannes Rückel, Dirk-André Clevert, Johannes Rübenthaler, Thomas Geyer
Publikováno v:
Diagnostics, Vol 11, Iss 2, p 313 (2021)
Background: This study aims to evaluate the potential benefits of structured reporting (SR) compared to conventional free-text reporting (FTR) in contrast-enhanced ultrasound (CEUS) of cystic renal lesions, based on the Bosniak classification. Method
Externí odkaz:
https://doaj.org/article/76403f8bea6445d7933d7b18c6b05141
Autor:
Vincent Schwarze, Johannes Rübenthaler, Saša Čečatka, Constantin Marschner, Matthias Frank Froelich, Bastian Oliver Sabel, Michael Staehler, Thomas Knösel, Thomas Geyer, Dirk-André Clevert
Publikováno v:
Medicina, Vol 56, Iss 12, p 692 (2020)
Background and objectives: The aim of the present retrospective single-center study is to evaluate the diagnostic performance of contrast-enhanced ultrasound (CEUS) for assessing Bosniak III complex renal cystic lesions with histopathological validat
Externí odkaz:
https://doaj.org/article/e86d26ecbd49490f83a8431464d4ae3d
Autor:
David Krug, Detlef Imhoff, Alfred Haidenberger, Nicole Heßler, Jane Schäfer, Stefan Huttenlocher, Georgios Chatzikonstantinou, Christoph Fürweger, Ulla Ramm, Inke R. König, Felix Chun, Michael Staehler, Claus Rödel, Alexander Muacevic, Reinhard Vonthein, Jürgen Dunst, Oliver Blanck
Publikováno v:
Strahlentherapie und Onkologie. 199:565-573
Purpose We report results of the first German prospective multicenter single-arm phase II trial (ARO 2013-06; NCT02635256) of hypofractionated robotic stereotactic body radiotherapy (SBRT) for patients with localized prostate cancer (HYPOSTAT). Metho